Colorectal cancer in patients with inflammatory bowel disease.
about
Inflammatory bowel disease associated neoplasia: A surgeon's perspectiveKRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.Herbal extract SH003 suppresses tumor growth and metastasis of MDA-MB-231 breast cancer cells by inhibiting STAT3-IL-6 signaling.Adenoma formation following limited ablation of p120-catenin in the mouse intestine.Epigenetic regulation of inflammatory cytokines and associated genes in human malignanciesPharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumorsRegulation of apoptosis during homeostasis and disease in the intestinal epithelium.Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformationRaf protects against colitis by promoting mouse colon epithelial cell survival through NF-kappaBDiagnostic yield of endomicroscopy for dysplasia in primary sclerosing cholangitis associated inflammatory bowel disease: a feasibility study.Aging and inflammation: etiological culprits of cancerOxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence.Beyond white light endoscopy: the role of optical biopsy in inflammatory bowel disease.Metachronous, colitis-associated rectal cancer that developed after sporadic adenocarcinoma in an adenoma in a patient with longstanding Crohn's disease: a case report.5-aminosalicylic acid interferes in the cell cycle of colorectal cancer cells and induces cell death modes.Transplantation of human umbilical mesenchymal stem cells attenuates dextran sulfate sodium-induced colitis in mice.
P2860
Q26774592-554F950B-7B5C-429C-9266-48F989E525B6Q33591865-E348A5F2-BE00-4012-8536-BB2092BD2664Q33757639-CBE4234F-98C3-48B5-9409-8AFCFB263D7CQ33911395-78226D5C-3178-4345-A570-65AE0A1CB2F9Q35178132-63474650-B425-4774-90FE-696BB037FDCEQ35832158-1EDE121C-8FA0-4319-A879-F28202258E3FQ36467014-569C5F8B-326A-480B-8556-50597CCAE12BQ36982054-BDA3A4DD-3BBA-4610-BE30-C64E72292A24Q37094120-1DEAD9D4-CCC9-4326-9457-7939D70F93BBQ37184203-00198B4D-7DEF-45B0-8984-664835417759Q37462069-1E0C22C0-FEAD-4E54-A360-1DF901486B48Q37996392-C8CB4CF0-458D-44B2-9666-AB55A62BE265Q38166709-C4F548D7-2A46-4DB8-906B-F301E0183881Q42991761-B54509B9-2FAC-408D-94D5-2BADA69B2A01Q43272637-B37730A3-743A-4A21-B0F4-40E8716EE444Q54401840-4325FAD9-8646-4456-9929-8A67AD080BC6
P2860
Colorectal cancer in patients with inflammatory bowel disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Colorectal cancer in patients with inflammatory bowel disease.
@ast
Colorectal cancer in patients with inflammatory bowel disease.
@en
type
label
Colorectal cancer in patients with inflammatory bowel disease.
@ast
Colorectal cancer in patients with inflammatory bowel disease.
@en
prefLabel
Colorectal cancer in patients with inflammatory bowel disease.
@ast
Colorectal cancer in patients with inflammatory bowel disease.
@en
P356
P1476
Colorectal cancer in patients with inflammatory bowel disease.
@en
P2093
Parsia A Vagefi
Walter E Longo
P304
P356
10.3816/CCC.2005.N.003
P407
P577
2005-01-01T00:00:00Z